Elevance Health (ELV) Shares Outstanding (Weighted Average) (2009 - 2026)

Elevance Health (ELV) has 18 years of Shares Outstanding (Weighted Average) data on file, last reported at $219.8 million in Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) fell 2.92% year-over-year to $219.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $219.8 million (down 2.92% YoY) and the FY2025 annual result came in at $224.0 million, down 3.32% from the prior year.
• Shares Outstanding (Weighted Average) fell to $219.8 million in Q1 2026 per ELV's latest filing, from $224.0 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $241.4 million in Q1 2022 and bottomed at $219.8 million in Q1 2026.
• The 5-year median for Shares Outstanding (Weighted Average) is $232.7 million (2024), against an average of $232.9 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) dropped 1.47%; it then retreated 3.32% in 2025.
• Tracing ELV's Shares Outstanding (Weighted Average) over 5 years: stood at $240.0 million in 2022, then retreated by 1.71% to $235.9 million in 2023, then fell by 1.78% to $231.7 million in 2024, then decreased by 3.32% to $224.0 million in 2025, then decreased by 1.88% to $219.8 million in 2026.
• Per Business Quant, the three latest ELV Shares Outstanding (Weighted Average) figures stand at $219.8 million (Q1 2026), $224.0 million (Q4 2025), and $225.0 million (Q3 2025).

Peer Comparison